Table 1.

Peak-aligned pairwise comparisons (individual drug groups)

p-values (t test)Core (control) vs. shell (control)Core (control) vs. core (cocaine)Shell (control) vs. shell (cocaine)
Peak [DA], µm0. 10.20.40.80.10.20.40.80.10.20.40.8
Peak0.870.020.970.320.030.001*0.070.660.810.420.940.03
Frequency0.007*0.001*0.540.910.040.280.100.850.030.200.430.34
AUC0.020.050.001*0.008*0.060.120.110.090.100.520.880.24
Rise velocity<0.0001*<0.0001*<0.0001*0.004*0.002*<0.0001*0.008*0.070.0004*0.060.060.07
Latency peak<0.0001*<0.0001*<0.0001*<0.0001*0.27<0.0001*0.120.003*<0.0001*0.020.220.53
Vmax<0.0001*<0.0001*<0.0001*0.010.0008*<0.0001*0.020.080.630.520.530.36
FWHH<0.0001*<0.0001*<0.0001*<0.0001*0.28<0.0001*0.150.003*<0.0001*0.140.670.93
Slope (T20–T80)<0.0001*<0.0001*0.520.800.840.050.980.980.410.370.210.009*
Baseline return0.0002*0.002*0.600.630.840.830.560.340.870.230.340.35
T20 latency<0.0001*<0.0001*<0.0001*<0.0001*0.16<0.0001*0.12<0.0001*<0.0001*0.070.690.89
T80 latency<0.0001*<0.0001*0.020.850.910.100.800.400.0006*0.870.410.08
  • Significance (p-value) of pairwise t tests at each peak bin (low [<0.1 μm DA], medium-low [0.1–0.2 μm DA], medium-high [0.2–0.4 μm DA], and high [0.4–0.8 μm DA]) between core control and shell control (left), core control and core cocaine (middle), and shell control and shell cocaine (right). Bold italics: *p < 0.01 (significant after Bonferroni correction); italics only: p < 0.05 (not significant after Bonferroni correction).